511
1
17
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T5091 | FM-381 | FM381 | JAK |
FM381 is a potent covalent reversible inhibitor of JAK3. FM-381 has an IC50 of 127 pM for JAK3, with 410, 2700 and 3600-fold selectivity over JAK1, JAK2 and TYK2, respectively. | |||
T18965 | DAF-FM DA | Diaminofluorescein-FM diacetate | Others |
DAF-FM DA is an agent to detect and quantify low concentrations of nitric oxide (NO). The fluorescence of DAF-FM can be detected by any instrument that can detect fluorescein. | |||
T22333 | FM-479 | Others | |
FM-479, an FM-381 structural analog, exhibits no inhibitory potency against JAK3 or other kinases when used at the FM-381 effective dosing range (100-300 nM). FM-479 is used as a negative control for FM-381. | |||
T68856 | FM-24 HCl | ||
FM-24 HCl is a long acting beta-adrenergic receptor antagonist. | |||
T31832 | FM-476 | ||
FM-476 is a negative control for FM-381. | |||
T20840 | Apaflurane | FM200,FM-200,FM 200 | |
Apaflurane is a chemical fire extinguishing agent. | |||
T23409 | FM4-64 | SynaptoRedTM C2 | Others |
FM4-64 (SynaptoRedTM C2) is a styryl dye that stains stably but does not fluoresce in aqueous solution.FM4-64 does not passively diffuse into the plasma membrane bilayer and must be actively transported across the membra... | |||
T11308 | FM26 | ROR | |
FM26 has a distinct isoxazole chemotype and effectively reduces IL-17a mRNA production in EL4 cells. FM26 is a potent and allosteric retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonists with an IC5... | |||
T36711 | FM19G11 | FM19G11,HIF-1alpha/2alpha Inhibitor | HIF |
FM19G11 is an inhibitor of hypoxia inducible factor (HIF) α-subunit (IC50 = 80 nM in hypoxia induced luciferase assay). | |||
T67568 | Fmoc-Met-OH | Fmoc-L-Met-OH | |
Fmoc-Met-OH (Fmoc-L-Met-OH) is an fmoc-based programmed synthesis of methionine derivatives. | |||
T64323 | Fmoc-Asp-OAll | Fmoc-L-aspartic acid a-allyl ester | Amino Acids and Derivatives |
Fmoc-Asp-OAll (Fmoc-L-aspartic acid a-allyl ester) is an aspartic acid derivative. | |||
TP1466 | Z-YVAD-FMK | Caspase | |
AA-Z-YVAD-FMK is a Irreversible caspase-1 inhibitor,with anti-inflammatory and anti-tumor activities. | |||
T64331 | Fmoc-L-Proline | Fmoc-Pro-OH | Amino Acids and Derivatives |
Fmoc-L-Proline (Fmoc-Pro-OH) is a proline derivative. | |||
T17955 | Fmoc-NH-PEG12-CH2CH2COOH | Others , PROTAC Linker | |
Fmoc-NH-PEG12-CH2CH2COOH is a PEG-based PROTAC linker. Fmoc-NH-PEG12-CH2CH2COOH can be used in the synthesis of PROTAC. | |||
T17963 | Fmoc-N-PEG7-acid | Others , PROTAC Linker | |
Fmoc-N-amido-PEG7-acid is a PEG-based PROTAC linker. Fmoc-N-amido-PEG7-acid can be used in the synthesis of PROTACs. | |||
T4286 | Fmoc-Val-Ala-PAB-OH | Fmoc-Val-Ala-PAB | Others , AChR |
Fmoc-Val-Ala-PAB-OH (Fmoc-Val-Ala-PAB) is a useful linker for making Antibody-Drug-Conjugation (ADC) conjugate for targeting drug delivery. It is also utilized in the synthesis of RGD peptidomimetic-paclitaxel conjugates... | |||
T5586 | CFMS Receptor Inhibitor II | c-Fms | |
cFMS Receptor Inhibitor II is a CSF1R kinase inhibitor | |||
T67566 | Fmoc-Lys(Boc)-OH | N-α-(Fmoc)-N-ε-(t-boc)-L-Lysine-OH | |
Fmoc-Lys(Boc)-OH (N-α-(Fmoc)-N-ε-(t-boc)-L-Lysine-OH) is a lysine derivative that acts as a reactive linker. | |||
T3263 | (6R,7S)-Cefminox sodium heptahydrate | Meicelin,Cefminox Sodium,Alteporina,Tencef | Antibiotic |
(6R,7S)-Cefminox sodium heptahydrate (Meicelin) is a broad-spectrum, bactericidal cephalosporin antibiotic. It is especially effective against Gram-negative and anaerobic bacteria. | |||
T22646 | CFM 4 | CFM-4,CFM4 | Apoptosis , APC |
CFM 4 is a potent small molecule CARP-1/APC-2 antagonist that prevents CARP-1 from binding to APC-2, contributes to G2M cell cycle arrest, and induces apoptosis, with an IC50 in the range of 10-15 μM.CFM 4 inhibits the g... | |||
T10643 | C-Fms-IN-1 | c-Fms | |
c-Fms-IN-1 is an inhibitor of c-FMS kinase (IC50 = 0.8 nM). | |||
T15303 | FMK 9a | Cysteine Protease , Autophagy | |
FMK 9a is an irreversible inhibitor of ATG4B with IC50 values of 80 and 73 nM in the TR-FRET and cellular-based LRA assays. | |||
T41345 | AFMK | Formyl-N-acetyl-5-methoxykynurenamine,Acetyl-N-formyl-5-methoxykynurenamine | Apoptosis , Free radical scavengers , Antioxidant , Endogenous Metabolite |
AFMK (Formyl-N-acetyl-5-methoxykynurenamine) is an active metabolite of Melatonin with antioxidant and free radical scavenging activity. AFMK is a modulator of apoptosis and improves the anti-tumor effect of Gemcitabine ... | |||
T24871 | TFMB-(S)-2-HG | TFMB(S)2HG,TFMB-S-2-HG,TFMB (S) 2 HG,TFMB S 2 HG | DNA Methyltransferase |
TFMB-(S)-2-HG (TFMB S 2 HG) is a highly effective inhibitor of TET2, the 5'-methylcytosine hydroxylase. Additionally, it significantly inhibits the EglN prolyl hydroxylases. With its unique properties, TFMB-(S)-2-HG hold... | |||
T72055 | FM04 | P-gp | |
FM04 is an orally active and highly potent inhibitor of P-glycoprotein (P-gp) with an EC50 value of 83 nM. FM04 can interact with Q1193 and I1115 in human P-gp nucleotide binding domain 2 (NBD2). Thereby disrupting the R... | |||
T7019 | Z-IETD-FMK | Z-IE(OMe)TD(OMe)-FMK,Caspase-8 Inhibitor | Caspase |
Z-IETD-FMK (Z-IE(OMe)TD(OMe)-FMK) is a selective caspase 8 inhibitor, which has cell permeable. | |||
T38709 | PFM39 | Others | |
PFM39 is a selective MRE11 nucleic acid exonuclease inhibitor and Mirin analog that prolongs mitosis.PFM39 inhibits HR and alleviates repair defects caused by EXO1/BLM depletion. | |||
T1070 | Cefmetazole sodium | Sodium cefmetazole | Antibacterial , Antibiotic |
Cefmetazole sodium (Sodium cefmetazole) is a semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types... | |||
T1190 | Cefmenoxime hydrochloride | Cefmenoxime hemihydrochloride,SCE-1365 hemihydrochloride | Antibacterial , Antibiotic , Antifection |
Cefmenoxime hydrochloride (Cefmenoxime hemihydrochloride) is a cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganis... | |||
T9396 | FMoc-Arg(Tos)-OH | Others | |
FMoc-Arg(Tos)-OH is a synthetic amino acid used in peptide synthesis, biochemistry and molecular biology. It is a Fmoc-protected amino acid used as an intermediate in peptide and protein synthesis for solid-phase peptide... | |||
TP1784L | FMRF acetate(74012-06-9 free base) | Others | |
FMRF acetate is a peptide consisting of 4 amino acid residues. | |||
T22334 | FMOC-3VVD-OH | Others | |
FMOC-3VVD-OH is an active chemical. | |||
T5916 | Fmoc-N-Me-Phe-OH | Fmoc-N-methyl-L-phenylalanine | Others , Parasite |
Fmoc-N-Me-Phe-OH (Fmoc-N-methyl-L-phenylalanine) is a Malaria Parasite inhibitor. | |||
TP2359 | FMOC-DL-7-AZATRYPTOPHAN | 2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-{1H-pyrrolo[2,3-b]pyridin-3-yl}propanoic acid | Others |
FMOC-DL-7-AZATRYPTOPHAN (2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-{1H-pyrrolo[2,3-b]pyridin-3-yl}propanoic acid) is a peptide | |||
T17978 | Fmoc-PEG12-NHS ester | Others , PROTAC Linker | |
Fmoc-PEG12-NHS ester is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome sys... | |||
T4678 | Fmoc-Val-Cit-PAB | Others | |
Fmoc-Val-Cit-PAB is a linker for antibody-drug-conjugation (ADC). | |||
T41312 | Fmoc-Lys-OH hydrochloride | PROTAC Linker | |
Fmoc-Lys-OH hydrochloride is a alkyl-chain-based PROTAC linker. Fmoc-Lys-OH hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | |||
T6738 | Z-FA-FMK | SARS-CoV , Cysteine Protease | |
Z-FA-FMK can irreversibly inhibit cysteine protease and also inhibit effector caspases. | |||
T17946 | Fmoc-Ala-Ala-Asn(Trt)-OH | Others | |
Fmoc-Ala-Ala-Asn(Trt)-OH is a cleavable linker vital in ADC synthesis. Fmoc-Ala-Ala-Asn(Trt)-OH joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled... | |||
T10580 | BOC-D-FMK | Apoptosis , Caspase | |
Boc-D-FMK is an irreversible, cell-permeable, and broad-spectrum caspase inhibitor and inhibits apoptosis stimulated by TNF-α (IC50: 39 µM). | |||
T6013 | Z-VAD(OMe)-FMK | Z-VAD-FMK,Z-Val-Ala-Asp(OMe)-FMK | Caspase |
Z-VAD(OMe)-FMK is a pan-caspase inhibitor with irreversible properties; Z-VAD(OMe)-FMK is also an inhibitor of ubiquitin C terminal hydrolase L1 (UCHL1), which is irreversibly modified by targeting the UCHL1 active site. | |||
T38662 | Fmoc-Gly-Thr(psi(Me,Me)pro)-OH | Others | |
Fmoc-Gly-Thr(psi(Me,Me)pro)-OH is a polypeptide composed of two amino acids. | |||
T7767 | FMoc-Val-Cit-PAB-PNP | Others | |
Fmoc-Val-Cit-PAB-PNP is a linker for Antibody-Drug-Conjugation (ADC). | |||
T65665 | Fmoc-Lys-OH | Amino Acids and Derivatives | |
Fmoc-Lys-OH is a lysine derivative commonly used in the synthesis of active compounds. | |||
T66645 | Fmoc-His-OH | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoic acid,(((9H-Fluoren-9-yl)methoxy)carbonyl)-L-histidine,FMOC-L-Histidine | |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoic acid is a histidine derivative. | |||
T15324 | Fmoc-NH-PEG8-NHS ester | PROTAC Linker | |
Fmoc-NH-PEG8-NHS ester is a PEG-based PROTAC linker that can be used in PROTAC synthesis[1]. | |||
T7643 | Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH | Fmoc-Ser-(GalNAc(Ac)3-alpha-D)-OH,Fmoc-Ser(Ac3AcNH-α-Gal)-OH,Fmoc-Ser[GalNAc(Ac)3-α-D]-OH | Others |
Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH (Fmoc-Ser(Ac3AcNH-α-Gal)-OH) is an anti-tumor drug | |||
T10775 | C-Fms-IN-2 | c-Fms | |
c-Fms-IN-2 is an inhibitor of c-FMS kinase (IC50 = 24 nM). | |||
TQ0310 | FMK | S6 Kinase | |
FMK is an irreversible inhibitor of RSK2 kinase. | |||
T9582 | CLEFMA | NF-κB | |
CLEFMA has anti-proliferative activity. CLEFMA inhibits tumor growth associated with NF-κB-regulated anti-inflammatory and anti-metastatic effects. |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T5S1708 | Dendrobine | Others , Influenza Virus | |
1. Dendrobine has a slight but demonstrable analgesic and antipyretic action. 2. Dendrobine produces moderate hyperglycemia, diminishes cardiac activity in large doses, lowers the blood pressure. 3. Dendrobine on the ele... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04801 | Fibromodulin Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
Fibromodulin (FMOD), an ECM small leucine-rich proteoglycan (SLRP), was reported to promote angiogenesis not only during wound healing, but also in optical and cutaneous angiogenesis-dependent diseases. The autocrine FM... | |||
TMPH-01807 | OLFML2B Protein, Human, Recombinant (His & Myc) | Human | HEK293 Cells |
OLFML2B Protein, Human, Recombinant (His & Myc) is expressed in HEK293 mammalian cells with N-10xHis and C-Myc tag. The predicted molecular weight is 86.6 kDa and the accession number is Q68BL8. | |||
TMPK-01482 | HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His & Avi) | Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple ... | |||
TMPK-01519 | HLA-A*02:01&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His & Avi) | Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple ... | |||
TMPK-01515 | HLA-A*02:01&B2M&AFP (FMNKFIYEI) Monomer Protein, Human, MHC (His & Avi) | Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple ... | |||
TMPH-01354 | FMR1NB Protein, Human, Recombinant (His & Myc) | Human | E. coli |
FMR1NB Protein, Human, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 15.4 kDa and the accession number is Q8N0W7. | |||
TMPH-00625 | FMN reductase Protein, E. coli, Recombinant (His) | E. coli | Baculovirus Insect Cells |
Catalyzes an NADPH-dependent reduction of FMN, but is also able to reduce FAD or riboflavin. | |||
TMPK-01483 | HLA-A*02:03&B2M&AFP (FMNKFIYEI) Monomer Protein, Human, MHC (His & Avi), Biotinylated | Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple ... | |||
TMPK-01484 | HLA-A*02:03&B2M&AFP (FMNKFIYEI) Monomer Protein, Human, MHC (His & Avi) | Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple ... | |||
TMPH-03461 | IFM1 Protein, S. cerevisiae, Recombinant (GST) | Saccharomyces cerevisiae | E. coli |
One of the essential components for the initiation of protein synthesis. Protects formylmethionyl-tRNA from spontaneous hydrolysis and promotes its binding to the 30S ribosomal subunits. Also involved in the hydrolysis o... | |||
TMPH-01287 | TUFM Protein, Human, Recombinant (His) | Human | E. coli |
Promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. Plays also a role in the regulation of autophagy and innate immunity. Recruits ATG5-ATG12 and NLRX1 at mitochon... | |||
TMPH-01760 | NEFM Protein, Human, Recombinant (His & Myc) | Human | E. coli |
Neurofilaments usually contain three intermediate filament proteins: NEFL, NEFM, and NEFH which are involved in the maintenance of neuronal caliber. May additionally cooperate with the neuronal intermediate filament prot... | |||
TMPY-03962 | AFM Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Afamin is an 87 kDa glycoprotein with five predicted N-glycosylation sites. Afamin's glycan abundance contributes to conformational and chemical inhomogeneity presenting great challenges for molecular structure determina... | |||
TMPK-01417 | HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled | Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple ... | |||
TMPK-01477 | HLA-A*02:01&B2M&AFP (FMNKFIYEI) Monomer Protein, Human, MHC (His & Avi), Biotinylated | Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple ... | |||
TMPK-01436 | HLA-A*02:01&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled | Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple ... | |||
TMPY-01416 | OLFM4 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Olfactomedin-4, also known as G-CSF-stimulated clone 1 protein, Antiapoptotic protein GW112, and OLFM4, is a secreted protein that contains one olfactomedin-like domain. The OLFM4 gene was recently reported to inhibit va... |